The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 20, 2025
Filed:
Dec. 10, 2024
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
Applicant:
Impax Laboratories, Llc, Bridgewater, NJ (US);
Inventors:
Ann Hsu, Hayward, CA (US);
Liang Dong, Hayward, CA (US);
Amy Ding, Hayward, CA (US);
Suneel Gupta, Hayward, CA (US);
Assignee:
Impax Laboratories, LLC, Bridgewater, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/50 (2006.01); A61K 31/198 (2006.01); A61K 31/216 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4808 (2013.01); A61K 9/0053 (2013.01); A61K 9/1652 (2013.01); A61K 9/5026 (2013.01); A61K 9/5042 (2013.01); A61K 9/5073 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 45/06 (2013.01); Y02A 50/30 (2018.01);
Abstract
The invention provides an oral solid formulation comprising (a) one or more controlled release components comprising a core comprising levodopa; and (b) one or more immediate release components comprising levodopa. The oral solid formulation also contains a decarboxylase inhibitor wherein the one or more controlled release components are substantially free of the decarboxylase inhibitor.